Ascend Laboratories LLC is recalling 38,841 bottles of Cephalexin for Oral Suspension (250 mg per 5 mL), a prescription antibiotic used to treat bacterial infections. The recall includes both 100 mL and 200 mL bottle sizes because the medication failed to meet impurity and degradation specifications during testing. This defect means the drug may not have the expected potency or could contain unintended chemical breakdown products, which could impact the effectiveness of the treatment.
The failure to meet impurity and degradation specifications may result in reduced drug efficacy or exposure to degradation products. This could lead to a less effective treatment for bacterial infections, potentially allowing the infection to persist or worsen.
Drug recall refund and consultation
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.